Cargando…
Primary CNS lymphoma commonly expresses immune response biomarkers
BACKGROUND: Primary central nervous system lymphoma (PCNSL) is rare and there is limited genomic and immunological information available. Incidental clinical and radiographic responses have been reported in PCNSL patients treated with immune checkpoint inhibitors. MATERIALS AND METHODS: To genetical...
Autores principales: | Ou, Alexander, Sumrall, Ashley, Phuphanich, Surasak, Spetzler, David, Gatalica, Zoran, Xiu, Joanne, Michelhaugh, Sharon, Brenner, Andrew, Pandey, Manjari, Kesari, Santosh, Korn, W Michael, Mittal, Sandeep, Westin, Jason, Heimberger, Amy B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067145/ https://www.ncbi.nlm.nih.gov/pubmed/32201861 http://dx.doi.org/10.1093/noajnl/vdaa018 |
Ejemplares similares
-
Correction to: Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
por: Dardis, Christopher, et al.
Publicado: (2021) -
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling
por: Dardis, Christopher, et al.
Publicado: (2021) -
Molecular alterations associated with improved outcome in patients with glioblastoma treated with Tumor-Treating Fields
por: Pandey, Manjari, et al.
Publicado: (2022) -
Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma
por: Kassab, Cynthia, et al.
Publicado: (2019) -
Rethinking medulloblastoma from a targeted therapeutics perspective
por: Hashimoto, Yuuri, et al.
Publicado: (2018)